105 related articles for article (PubMed ID: 6696520)
1. Free thiomalate in plasma and urine of patients receiving sodium aurothiomalate.
Rudge SR; Perrett D; Swannell AJ
Ann Rheum Dis; 1984 Feb; 43(1):66-9. PubMed ID: 6696520
[TBL] [Abstract][Full Text] [Related]
2. Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.
Jellum E; Munthe E
Ann Rheum Dis; 1982 Aug; 41(4):431-2. PubMed ID: 6810769
[TBL] [Abstract][Full Text] [Related]
3. Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?
Rudge SR; Perrett D; Swannell AJ; Drury PL
J Rheumatol; 1984 Apr; 11(2):150-2. PubMed ID: 6427462
[TBL] [Abstract][Full Text] [Related]
4. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
Rudge SR; Perrett D; Swannell AJ
Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348
[TBL] [Abstract][Full Text] [Related]
5. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
Jellum E; Munthe E; Guldal G; Aaseth J
Ann Rheum Dis; 1980 Apr; 39(2):155-8. PubMed ID: 6770766
[TBL] [Abstract][Full Text] [Related]
6. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
Jellum E; Munthe E; Guldal G; Aaseth J
Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
[TBL] [Abstract][Full Text] [Related]
8. The determination of thiomalate in physiological fluids by high-performance liquid chromatography and electrochemical detection.
Rudge SR; Perrett D; Drury PL; Swannell AJ
J Pharm Biomed Anal; 1983; 1(2):205-10. PubMed ID: 16867819
[TBL] [Abstract][Full Text] [Related]
9. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
Svensson A; Theander J
Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
11. Cultured human cells can acquire resistance to the antiproliferative effect of sodium aurothiomalate.
Glennås A; Rugstad HE
Ann Rheum Dis; 1986 May; 45(5):389-95. PubMed ID: 3087299
[TBL] [Abstract][Full Text] [Related]
12. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
Danpure CJ; Fyfe DA; Gumpel JM
Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
[TBL] [Abstract][Full Text] [Related]
13. Use of sodium aurothiomalate during lactation.
Bennett PN; Humphries SJ; Osborne JP; Clarke AK; Taylor A
Br J Clin Pharmacol; 1990 Jun; 29(6):777-9. PubMed ID: 2116162
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion.
Gottlieb NL; Smith PM; Smith EM
Arthritis Rheum; 1974; 17(2):171-83. PubMed ID: 4814979
[No Abstract] [Full Text] [Related]
15. Cultured human cells with high levels of gold-binding cytosolic metallothionein are not resistant to the growth inhibitory effect of sodium aurothiomalate.
Glennås A; Rugstad HE
Ann Rheum Dis; 1986 Feb; 45(2):101-9. PubMed ID: 3080971
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
Iqbal MS; Saeed M; Taqi SG
Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
[TBL] [Abstract][Full Text] [Related]
17. Patterns of gold levels in urine, serum, and saliva in patients with rheumatoid arthritis undergoing chrysotherapy.
Heath MJ; Gillett GT; Swannell AJ; Williams CR; Palmer T
Ann Rheum Dis; 1987 Nov; 46(11):827-9. PubMed ID: 3122674
[TBL] [Abstract][Full Text] [Related]
18. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
[TBL] [Abstract][Full Text] [Related]
19. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
[TBL] [Abstract][Full Text] [Related]
20. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
